Description
Cyclin D1, when used in tandem with CD5, CD10 and CD23, is a reliable immunohistochemical marker for the mantle cell lymphoma. Studies have shown that Cyclin D1 is a clinical informative marker for invasive breast cancer. Due to the superior technology in the development of this antibody, its binding capacity exceeds mouse monoclonal antibodies and is virtually background free.
Specifications
| INTENDED USE | RUO |
|---|---|
| SPECIES REACTIVITY | Human, Mouse, Rat |
| SOURCE | Rabbit Monoclonal |
| CLONE | SP4 |
| ISOTYPE | IgG |
| ANTIGEN | Cyclin D1 |
| LOCALIZATION | Nuclear |
| POSITIVE CONTROL | Mantle cell lymphoma and breast cancer |
